The Creative Engagement Group buys Cormis
The move is Huntsworth’s first acquisition under the ownership of Clayton, Dubilier & Rice
Read More
Tag: TCEG
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
